The Impact of Letermovir (LTV) Prophylaxis on Early Cytomegalovirus Infection (CMVi) and Outcomes in the Adult Allogeneic Hematopoietic Cell Transplantation (alloHCT) Recipients with High- Risk Donor Type

被引：0
|
作者：
Dadwal, Sanjeet S. [1 ]
Yang, Dongyun [2 ]
Marcucci, Guido [3 ]
Mokhtari, Sally [4 ]
Tegtmeier, Bernard [5 ]
Palmer, Joycelynne [6 ]
Smith, Eileen P. [7 ]
Taplitz, Randy [1 ]
Artz, Andrew S. [8 ]
Curtin, Peter T. [7 ]
Spielberger, Ricardo [7 ,9 ]
Salhotra, Amandeep [7 ]
Stein, Anthony S. [10 ]
Forman, Stephen J. [11 ]
Al Malki, Monzr M. [7 ]
Nakamura, Ryotaro [12 ]
机构：
[1] City Hope Natl Med Ctr, Div Infect Dis, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol Malignancies Translat Sci, Gehr Family Ctr Leukemia Res,Hematol Malignancies, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Clin Translat Program Dev, 1500 E Duarte Rd, Duarte, CA 91010 USA
[5] City Hope Natl Med Ctr, Dept Qual Risk & Regulatory Management, 1500 E Duarte Rd, Duarte, CA 91010 USA
[6] City Hope Natl Med Ctr, Dept Computat & Quantitat Med BRI, 1500 E Duarte Rd, Duarte, CA 91010 USA
[7] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA
[8] City Hope Natl Med Ctr, Dept Hematol HCT, Duarte, CA USA
[9] Southern Calif Kaiser Permanente, Bone Marrow Transplant Program, Los Angeles, CA USA
[10] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[11] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol HCT, Duarte, CA USA
[12] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153784
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1776
引用
收藏
页码：1776 / +
页数：6
相关论文
共 50 条
  • [1] Real World Experience of Letermovir (LTV) Prophylaxis (Px) for the Prevention of Cytomegalovirus Infection (CMVi) in the Adult CMV Seropositive Recipients (R plus ) of Allogeneic Hematopoietic Cell Transplantation (HCT) Patients (pts)
    Dadwal, Sanjeet S.
    Al Malki, Monzr M.
    Yang, Dongyun
    Tegtmeier, Bernard R.
    Ross, Justine
    Mokhtari, Sally
    Marcucci, Guido
    Palmer, Joycelynne
    Salhotra, Amandeep
    Dickter, Jana
    O'Donnell, Margaret R.
    Smith, Eileen
    Karanes, Chatchada
    Snyder, David S.
    Mei, Matthew
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Stein, Anthony S.
    Sandhu, Karamjeet S.
    Spielberger, Ricardo
    Nademanee, Auayporn
    Ito, James I.
    Forman, Stephen J.
    Zaia, John A.
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [2] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
    Katsuto Takenaka
    Shigeo Fuji
    Toshihiro Matsukawa
    Naoyuki Uchida
    Takeshi Kobayashi
    Masatsugu Tanaka
    Takahide Ara
    Kazuhiro Ikegame
    Yukiyasu Ozawa
    Yoshinobu Kanda
    Masashi Sawa
    Yumiko Maruyama
    Takahiro Fukuda
    Hirohisa Nakamae
    Takafumi Kimura
    Masao Ogata
    Sachiko Seo
    Yoshiko Atsuta
    Keitaro Matsuo
    Hideki Nakasone
    Annals of Hematology, 2024, 103 : 285 - 296
  • [3] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
    Takenaka, Katsuto
    Fuji, Shigeo
    Matsukawa, Toshihiro
    Uchida, Naoyuki
    Kobayashi, Takeshi
    Tanaka, Masatsugu
    Ara, Takahide
    Ikegame, Kazuhiro
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Sawa, Masashi
    Maruyama, Yumiko
    Fukuda, Takahiro
    Nakamae, Hirohisa
    Kimura, Takafumi
    Ogata, Masao
    Seo, Sachiko
    Atsuta, Yoshiko
    Matsuo, Keitaro
    Nakasone, Hideki
    ANNALS OF HEMATOLOGY, 2023, 103 (1) : 285 - 296
  • [4] Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients
    Van Hecke, Sam
    Calcoen, Bas
    Lagrou, Katrien
    Maertens, Johan
    FUTURE MICROBIOLOGY, 2019, 14 (03) : 175 - 184
  • [5] LETERMOVIR FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN ADULT CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Duarte, R.
    Marty, F.
    Ljungman, P.
    Chemaly, R.
    Maertens, J.
    Snydman, D.
    Blumberg, E.
    Einsele, H.
    Boeckh, M.
    Teal, V.
    Wan, H.
    Kartsonis, N.
    Leavitt, R.
    Badshah, C.
    HAEMATOLOGICA, 2017, 102 : 331 - 332
  • [6] Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients
    Han, Gyuri
    Stern, Anat
    Lee, Yeon Joo
    Li, Yuxuan
    Dahi, Parastoo B.
    Tamari, Roni
    Gyurkocza, Boglarka
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Shaffer, Brian
    Perales, Miguel-Angel
    Obeid, Karam M.
    Young, Jo-Anne H.
    Papanicolaou, Genovefa A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02):
  • [7] Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong
    Chan, Thomas Sau-Yan
    Cheng, Sally Shuk-Yee
    Chen, Wei-Ting
    Hsu, Danny Chung
    Chau, Rene Wing-Yan
    Kang, Suk Hyun
    Alsumali, Adnan
    Kwong, Yok-Lam
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (12) : 1485 - 1492
  • [8] Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience
    Desai, Nihar
    Pasic, Ivan
    Law, Arjun D.
    Lam, Wilson
    Gerbitz, Armin
    Viswabandya, Auro
    Kim, Dennis D.
    Kumar, Rajat
    Mattsson, Jonas
    Novitzky-Basso, Igor
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (04) : 477 - 484
  • [9] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
  • [10] Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxis
    Chen, Kaiwen
    Arbona-Haddad, Esther
    Cheng, Matthew P.
    McDonnell, Anne M.
    Gooptu, Mahasweta
    Orejas, Jose L.
    Timblin, Kaitlyn
    Silverman, Emily
    Al-Hamed, Rama
    Soiffer, Robert J.
    Hammond, Sarah P.
    Marty, Francisco M.
    TRANSPLANT INFECTIOUS DISEASE, 2021,
12345